BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27716267)

  • 1. Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review.
    Becerra V; Ávila M; Jimenez J; Cortes-Sanabria L; Pardo Y; Garin O; Pont A; Alonso J; Cots F; Ferrer M;
    BMC Health Serv Res; 2016 Oct; 16(1):541. PubMed ID: 27716267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.
    Schroeck FR; Jacobs BL; Bhayani SB; Nguyen PL; Penson D; Hu J
    Eur Urol; 2017 Nov; 72(5):712-735. PubMed ID: 28366513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(11):1-172. PubMed ID: 28744334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
    Ramsay C; Pickard R; Robertson C; Close A; Vale L; Armstrong N; Barocas DA; Eden CG; Fraser C; Gurung T; Jenkinson D; Jia X; Lam TB; Mowatt G; Neal DE; Robinson MC; Royle J; Rushton SP; Sharma P; Shirley MD; Soomro N
    Health Technol Assess; 2012; 16(41):1-313. PubMed ID: 23127367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial.
    Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
    J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-utility analysis of laparoscopic radical prostatectomy and robotic-assisted laparoscopic radical prostatectomy in men with localized prostate cancer in Thailand.
    Ratchanon S; Apiwattanasawee P; Prasopsanti K
    J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S14-20. PubMed ID: 25764608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
    Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic literature review of cost-effectiveness analyses of robotic-assisted radical prostatectomy for localised prostate cancer.
    Song C; Cheng L; Li Y; Kreaden U; Snyder SR
    BMJ Open; 2022 Sep; 12(9):e058394. PubMed ID: 36127082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.
    Basto M; Sathianathen N; Te Marvelde L; Ryan S; Goad J; Lawrentschuk N; Costello AJ; Moon DA; Heriot AG; Butler J; Murphy DG
    BJU Int; 2016 Jun; 117(6):930-9. PubMed ID: 26350758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing resources in the local treatment of prostate cancer: A summary of cost-effectiveness studies.
    Muralidhar V; Nguyen PL
    Urol Oncol; 2017 Feb; 35(2):76-85. PubMed ID: 27473636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multidimensional Analysis of Prostate Surgery Costs in the United States: Robotic-Assisted versus Retropubic Radical Prostatectomy.
    Bijlani A; Hebert AE; Davitian M; May H; Speers M; Leung R; Mohamed NE; Sacks HS; Tewari A
    Value Health; 2016 Jun; 19(4):391-403. PubMed ID: 27325331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cost-effectiveness of robot-assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of men with localised prostate cancer: a health technology assessment from the perspective of the UK National Health Service.
    Close A; Robertson C; Rushton S; Shirley M; Vale L; Ramsay C; Pickard R
    Eur Urol; 2013 Sep; 64(3):361-9. PubMed ID: 23498062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in the UK.
    Labban M; Dasgupta P; Song C; Becker R; Li Y; Kreaden US; Trinh QD
    JAMA Netw Open; 2022 Apr; 5(4):e225740. PubMed ID: 35377424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
    Reddy D; van Son M; Peters M; Bertoncelli Tanaka M; Dudderidge T; Cullen E; Ho CLT; Hindley RG; Emara A; McCracken S; Orczyk C; Shergill I; Mangar S; Nigam R; Virdi J; Moore CM; Arya M; Shah TT; Winkler M; Emberton M; Falconer A; Belsey J; Ahmed HU
    J Med Econ; 2023; 26(1):1099-1107. PubMed ID: 37656223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. da Vinci and Open Radical Prostatectomy: Comparison of Clinical Outcomes and Analysis of Insurance Costs.
    Niklas C; Saar M; Berg B; Steiner K; Janssen M; Siemer S; Stöckle M; Ohlmann CH
    Urol Int; 2016; 96(3):287-94. PubMed ID: 26159050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Lee PA; McMahon PM
    Ann Intern Med; 2013 Jun; 158(12):853-60. PubMed ID: 23778902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis.
    Cooperberg MR; Ramakrishna NR; Duff SB; Hughes KE; Sadownik S; Smith JA; Tewari AK
    BJU Int; 2013 Mar; 111(3):437-50. PubMed ID: 23279038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Economic Evaluations of the Use of Robotic Assisted Laparoscopy in Surgery Compared with Open or Laparoscopic Surgery.
    Tandogdu Z; Vale L; Fraser C; Ramsay C
    Appl Health Econ Health Policy; 2015 Oct; 13(5):457-67. PubMed ID: 26239361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
    Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
    J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.